CD8A and neoplasm: Tumor-specific endogenous CD8+ T cell responses have been described in HCC using IFN-y response upon stimulation with tumor cell lysates or by stimulation of PBMC with selected tumor-associated peptides or peptide pools in enzyme-linked immunosorbent (ELISPOT) assays [15, 17].